Categories: Wire Stories

Mitsubishi Electric, Okayama University, and Osaka University Develop Magnetic Particle Imaging Device Capable of Producing Images of Human Brain

The world’s first high-sensitivity imaging device capable of operating at low frequencies with compact power supply, will facilitate diagnosis of pre-Alzheimer’s

TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503), Okayama University and Osaka University’s Graduate School of Engineering announced today that they have developed a magnetic particle imaging device capable of sensitive imaging of magnetic particles in an area equivalent in size to that of the human brain, in a project supported by the Japan Agency for Medical Research and Development (AMED). The device operates at low frequencies of 1 kHz or less, a world-first, allowing the use of a significantly smaller power supply unit. The utilization of this device to image magnetic particles that bind to amyloid-β, the causative agent of Alzheimer’s, will allow the accumulation and distribution of amyloid-β to be quantified. The aim is to allow imaging-based assessments of the likelihood of Alzheimer’s developing prior to the onset of the disease.


The number of dementia patients aged 65 and older in Japan is expected to reach 7 million in 2025. Significant statistical findingsindicate that Alzheimer’s accounts for 67.6% of these dementia cases. In June of this year, Japan enacted the Dementia Basic Law, aimed at advancing dementia prevention efforts. In August, a panel of experts from Japan’s Ministry of Health, Labour and Welfare gave a green light for the manufacture and sale of a drug that targets the accumulation of amyloid-β in the brain, a potential factor in the development of Alzheimer’s, thereby inhibiting the progression of the disease. Initiating medication early during a phase of low amyloid-β accumulation in the brain has been shown to help suppress the onset of the disease. This underscores the necessity for technology capable of measuring both the accumulation and distribution of amyloid-β.

For the full text, please visit: www.MitsubishiElectric.com/news/

Contacts

Media Inquiries
Takeyoshi Komatsu

Public Relations Division

Mitsubishi Electric Corporation

Tel: +81-3-3218-2346

prd.gnews@nk.MitsubishiElectric.co.jp
www.MitsubishiElectric.com/news/

Alex

Recent Posts

MSIG Singapore Appoints Inova Care to Enhance Health Insurance Claims Management

SINGAPORE - Media OutReach Newswire - 15 January 2025 - MSIG Singapore is pleased to…

2 hours ago

Allianz Risk Barometer 2025: Business interruption top business risk in Asia

Companies identify Business interruption as their top business concern for the year ahead (37% of…

3 hours ago

TDCX Singapore reinforces data privacy commitment with Data Protection Trustmark Certification

SINGAPORE - Media OutReach Newswire - 15 January 2025 - TDCX Singapore, an award-winning digital…

3 hours ago

CoreNutrition Introduces Three Leading Korean Health Brands to Hong Kong: Tailored Solutions for Women’s Care, Weight Management, and Digestive Health

CoreNutrition: Your One-Stop Destination for Premium Korean Wellness HONG KONG SAR - Media OutReach Newswire…

12 hours ago

Top 6 Best Places to Work in Jordan for 2024 revealed

AMMAN, JORDAN - Media OutReach Newswire - 14 January 2025 - The 2024 top 6…

14 hours ago

The world’s 30 Best Places to Work for 2024 revealed

NEW YORK, USA - Media OutReach Newswire - 14 January 2025 – The highly anticipated…

15 hours ago